14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
CISS vs SB: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Safe Bulkers, Inc. (SB) is the stronger overall head-to-head candidate over C3is Inc. (CISS) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). CISS carries a Unified Composite Score of 33.6/100 (SELL) at $1.23 (N/M Forward P/E, 24.6% operating margin), whereas SB carries 56.5/100 (HOLD) at $7.40 (9.2x Forward P/E, 36.9% operating margin).
Growth vs. Quality Trade-Off: SB earns the overall head-to-head edge with a stronger Unified Composite Score (56.5/100 HOLD vs. CISS 33.6/100 SELL) and 0.69β · 43% Vol risk profile, whereas CISS leads top-line expansion (+249.0% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: CISS is currently in a Breakdown options structure phase (RSI 53.6); meanwhile SB is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 40.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CISS vs SB. Trailing 12-month operating profitability (CISS 24.6% vs SB 36.9%) and valuation multiples (CISS N/M vs SB 9.2x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Marine Shipping value chain with $991,199 market capitalization and 24.6% operating margin.
OpEx & R&D Reinvestment43.5% of Rev ($15.8B)
90D Engineering Disclosures0 Published
SB Moat ProfileHigh-Margin Pricing Power Moat
Marine Shipping Operator
Competes within the Marine Shipping value chain with $864.0M market capitalization and 36.9% operating margin.
OpEx & R&D Reinvestment28.6% of Rev ($93M)
90D Engineering Disclosures0 Published
Investor FAQ CISS vs SB Key Questions & Quantitative Answers
As of Nov 20, 2026, Safe Bulkers, Inc. (SB) is the stronger overall head-to-head candidate over C3is Inc. (CISS) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). CISS carries a Unified Composite Score of 33.6/100 (SELL) at $1.23 (N/M Forward P/E, 24.6% operating margin), whereas SB carries 56.5/100 (HOLD) at $7.40 (9.2x Forward P/E, 36.9% operating margin). Growth vs. Quality Trade-Off: SB earns the overall head-to-head edge with a stronger Unified Composite Score (56.5/100 HOLD vs. CISS 33.6/100 SELL) and 0.69β · 43% Vol risk profile, whereas CISS leads top-line expansion (+249.0% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: CISS is currently in a Breakdown options structure phase (RSI 53.6); meanwhile SB is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 40.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CISS leads the Growth & Scale pillar: CISS posts +249.0% YoY revenue growth and +193.3% YoY earnings growth on $36.2B TTM revenue (68.1% gross margin, 24.6% operating margin), compared with SB at +24.6% YoY revenue growth and +129.5% YoY earnings growth on $325M TTM revenue (65.5% gross margin, 36.9% operating margin). On trailing 12-month operating scale, CISS generates $36.2B in USD-normalized revenue versus $325M for SB. In operating R&D and SG&A reinvestment, CISS deploys 43.5% of Rev ($15.8B) (0 90-day corporate R&D disclosures) versus 28.6% of Rev ($93M) (0 disclosures) for SB.
SB screens cheaper on headline valuation multiples. CISS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (36.9% EBITDA margin), whereas SB trades at 9.2x Forward P/E, 7.7x Trailing P/E, 3.33x PEG, and 2.7x EV/Revenue (55.0% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CISS (17.1% ROE) versus SB (11.9% ROE) capital efficiency.
In options market volatility and institutional positioning, CISS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (11.91β · 1054% Vol realized risk). By comparison, SB carries 26.4% implied volatility (5th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.69β · 43% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.